Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-07-24

FDA Approved: LOTRONEX — Supplemental Application (Legacy Pharma USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Lotronex (alosetron hydrochloride) submitted by Legacy Pharma USA Inc. The snippet does not specify the exact nature…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOTRONEX (alosetron hydrochloride)

Snippet

SUPPL AP for LOTRONEX (ALOSETRON HYDROCHLORIDE)